Cambridge Investment Research Advisors
CGEN icon

Cambridge Investment Research Advisors’s Compugen CGEN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,250
Closed -$17K – 3955
2025
Q4 		$17K Hold
11,250
– – ﹤0.01% 3794
2025
Q3 		$17K Hold
11,250
– – ﹤0.01% 3696
2025
Q2 		$19K Sell
11,250
-275
-2% -$408 ﹤0.01% 3580
2025
Q1 		$17K Hold
11,525
– – ﹤0.01% 3465
2024
Q4 		$18K Buy
+11,525
New +$18.7K ﹤0.01% 3428
2020
Q2 		– Sell
-10,975
Closed -$80K – 2462
2020
Q1 		$80K Buy
+10,975
New +$86.2K ﹤0.01% 2131
2018
Q1 		– Sell
-11,575
Closed -$29K – 2159
2017
Q4 		$29K Sell
11,575
-2,000
-15% -$5.95K ﹤0.01% 2083
2017
Q3 		$52K Sell
13,575
-8,920
-40% -$31K ﹤0.01% 1956
2017
Q2 		$85K Sell
22,495
-339
-1% -$1.41K ﹤0.01% 1857
2017
Q1 		$98K Sell
22,834
-3,900
-15% -$18K ﹤0.01% 1701
2016
Q4 		$136K Buy
26,734
+4,600
+21% +$27.5K ﹤0.01% 1568
2016
Q3 		$139K Buy
+22,134
New +$150K ﹤0.01% 1631

Other funds holding CGEN

SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return

Cambridge Investment Research Advisors's CGEN Position: Q1 2026 in Review

Cambridge Investment Research Advisors sold out of Compugen (CGEN) in Q1 2026, closing a stake of 11,250 shares — an estimated $17K sold.

Cambridge Investment Research Advisors first reported a position in CGEN in Q3 2016 and held it in 12 quarters. The position peaked at $139K in Q3 2016. 78 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.

  • Cambridge Investment Research Advisors reported no remaining Compugen position as of Q1 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 11,250 Compugen shares in Q1 2026, an estimated $17K.
  • Cambridge Investment Research Advisors first reported a position in Compugen in Q3 2016 and held it in 12 quarters.
  • Cambridge Investment Research Advisors's Compugen position peaked at $139K in Q3 2016.
  • 78 funds tracked by Wall St. Rank held Compugen as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.